Skip to main content
Clinical Trials/NCT05855031
NCT05855031
Recruiting
Not Applicable

The Liver Care Trial: Screening for Liver Disease in Individuals Attending Treatment for Alcohol Use Disorder - a Randomized Controlled Study

Zealand University Hospital2 sites in 1 country408 target enrollmentMay 8, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alcoholic Liver Disease
Sponsor
Zealand University Hospital
Enrollment
408
Locations
2
Primary Endpoint
Alcohol abstinence or light consumption (≤ 10 units/week) the last 30 days (yes/no) assessed 6 months since randomization
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to evaluate the efficacy of screening for liver disease with liver stiffness measurement on abstinence or light consumption after 6 months in individuals who are receiving treatment for alcohol use disorder and without a history of liver disease. The investigators will conduct a randomized controlled trial with concealed allocation comparing A) an invitation to a liver stiffness measurement, blood sampling and leaflet on alcohol-related disease (intervention) with B) an invitation to blood sampling (control). The primary outcome is 'abstinence or light consumption' (≤ 10 units/week) throughout the last months, and assessed 6 months after randomization.

Registry
clinicaltrials.gov
Start Date
May 8, 2023
End Date
May 1, 2027
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Attending outpatient treatment for alcohol use disorder (international classification of disease version 10: F102: alcohol dependence or F101: harmful alcohol use) at Novavi Køge or Novavi Roskilde
  • Informed written consent

Exclusion Criteria

  • Not speaking Danish or English
  • Severe liver disease (known by the participant)

Outcomes

Primary Outcomes

Alcohol abstinence or light consumption (≤ 10 units/week) the last 30 days (yes/no) assessed 6 months since randomization

Time Frame: Assessed 6 months after randomization

Assessed By telephone interview or health record

Secondary Outcomes

  • Heavy drinking days last 30 days(Assessed 6 months after since randomization)
  • Change in AUDIT-C score (yes or no) since randomization(6 months after randomization)

Study Sites (2)

Loading locations...

Similar Trials